INTERNATIONAL PATENT: ELLIPSES PHARMA LTD FILES APPLICATION FOR "COMBINATIONS OF CCT241736 AND VENETOCLAX, OR OF CCT241736, VENETOCLAX AND AZACITIDINE FOR USE IN THE TREATMENT OF CANCER"

GENEVA, Jan. 26 -- ELLIPSES PHARMA LTD (10 Stratton StreetLondon W1J 8LG) filed a patent application (PCT/GB2025/051575) for "COMBINATIONS OF CCT241736 AND VENETOCLAX, OR OF CCT241736, VENETOCLAX AND AZACITIDINE FOR USE IN THE TREATMENT OF CANCER" on Jul 16, 2025. With publication no. WO/2026/017996, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PATEL, Sital (c/o Ellipses Pharma Ltd10 Stratton StreetLondon Greater London W1J 8LG), FISHER, Geoff (c/o Ellipses Pharma Ltd10 Stratton StreetLondon Greater London W1J 8LG), AR...